New hope for rare tumors: drug shows promise in japanese trial
NCT ID NCT05077384
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 21 times
Summary
This study tested the drug surufatinib in 36 Japanese patients with neuroendocrine tumors that had stopped responding to standard treatments. The goal was to check safety and see if tumors shrank. Patients took the drug by mouth, and doctors monitored side effects and tumor changes. The study is complete, and results help guide future use of surufatinib for this cancer type.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Aichi Cancer Centre
Nagoya, 464-8681, Japan
-
Fukuoka Sanno Hospital
Fukuoka, 814-0001, Japan
-
Hokkaido University Hospital
Sapporo, 060-8648, Japan
-
Kagawa University Hospital
Kagawa, 761-0793, Japan
-
Kansia Electric Power Hospital
Osaka, 553-0003, Japan
-
Kyorin University Hospital
Mitaka, 181-8611, Japan
-
Kyoto University Hospital
Kyoto, 606-8507, Japan
-
Kyushu University Hospital
Fukuoka, 812-0054, Japan
-
National Cancer Centre Hospital
Tokyo, 104-004, Japan
-
National Cancer Centre Hospital East
Kashiwa-shi, 277-8577, Japan
-
Tohoku University Hospital
Sendai, 890-8574,, Japan
-
Yokohama City University Hospital
Yokohama, 236-0004, Japan
Conditions
Explore the condition pages connected to this study.